DHR

Over the past six months, Danaher's stock has experienced some notable movements. As of May 8, 2026, the stock was down 12.76% over the past 30 days and down 12.14% for the past 12 months. In April 2026, Danaher reported Q1 2026 adjusted EPS of $2.06, surpassing the consensus estimate of $1.94, but revenue for Q1 came in at $5.95 billion, slightly below the $6 billion consensus. Several large firms, including Goldman Sachs and Wolfe Research, reduced their price targets for DHR, though the consensus remained a "Moderate Buy."